This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Trump turnabout on China student visas renews trade secret threat

By Nick Robertson ( June 11, 2025, 21:47 GMT | Comment) -- While some Republicans applauded the State Department’s promise last month to “aggressively retract” student visas from some Chinese citizens who study in the US, President Trump said today that visas are part of a broader US-China preliminary trade deal. The State Department effort was intended to help combat Chinese trade secret theft in the US, though one China IP expert told MLex the move is an attempt to paint with too broad a brush.A resumption of normal student relations are part of a preliminary trade deal between the US and China, President Trump said today in an online post, a retreat from a State Department announcement last month promising to reduce the number of Chinese students studying in the US. Backing out of the move could again threaten American intellectual property from Chinese trade secret theft, according to supporters of the ban....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections